Cargando…
miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
In hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co‐infected patients, HIV enhances HCV replication and liver damage. Several microRNAs (miRNAs), active in pro‐fibrotic and inflammatory pathways, have been implicated in the pathogenesis of this phenomenon. However, these miRNAs have bee...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360178/ https://www.ncbi.nlm.nih.gov/pubmed/33818800 http://dx.doi.org/10.1002/jmv.26999 |
_version_ | 1783737694641192960 |
---|---|
author | Bulfoni, Michela Pravisani, Riccardo Dalla, Emiliano Cesselli, Daniela Hidaka, Masaaki Di Loreto, Carla Eguchi, Susumu Baccarani, Umberto |
author_facet | Bulfoni, Michela Pravisani, Riccardo Dalla, Emiliano Cesselli, Daniela Hidaka, Masaaki Di Loreto, Carla Eguchi, Susumu Baccarani, Umberto |
author_sort | Bulfoni, Michela |
collection | PubMed |
description | In hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co‐infected patients, HIV enhances HCV replication and liver damage. Several microRNAs (miRNAs), active in pro‐fibrotic and inflammatory pathways, have been implicated in the pathogenesis of this phenomenon. However, these miRNAs have been tested only in explanted cirrhotic livers, when the liver damage has become chronic and irreversible. No data are available on the early phase of viral infection, such as early after liver transplantation (LT). In the present study, the expression of miR‐101, miR‐122, miR‐155, miR‐192, miR‐200c, miR‐338, and miR‐532 was determined by quantitative real‐time polymerase chain reaction in liver biopsies of HCV (n = 19) and HCV/HIV‐infected (n = 20) LT recipients, as well as in a control group (n = 18) of noninfected patients, transplanted for alcoholic cirrhosis. The timing of liver biopsy was 6 months post‐LT. None of the patients was treated with direct‐acting anti‐HCV drugs. All co‐infected recipients had suppressed HIV viral load. Grading and staging were assessed according to the Ishak Classification. HCV and HIV viral load were measured in the sera. miR‐101 (p = .03), miR‐122 (p = .012), and miR‐192 (p = .038) were significantly downregulated in HCV/HIV co‐infected and HCV mono‐infected recipients when compared with noninfected recipients, and such downregulation was more pronounced in co‐infected ones. Moreover, in co‐infected recipients but not in mono‐infected ones, miR‐101 inversely correlated with the peripheral HCV‐RNA levels (r = .41, p = .04) and miR‐122 inversely correlated with peripheral HCV‐RNA levels (r = .49, p = .03) and with the histological grading (r = .51, p = .02). In conclusion, as early as 6 months after LT, the presence of HIV‐HCV co‐infection enhanced a significant downregulation of certain miRNAs that showed a direct correlation with HCV viral load and liver inflammation. |
format | Online Article Text |
id | pubmed-8360178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83601782021-08-17 miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation Bulfoni, Michela Pravisani, Riccardo Dalla, Emiliano Cesselli, Daniela Hidaka, Masaaki Di Loreto, Carla Eguchi, Susumu Baccarani, Umberto J Med Virol Research Articles In hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co‐infected patients, HIV enhances HCV replication and liver damage. Several microRNAs (miRNAs), active in pro‐fibrotic and inflammatory pathways, have been implicated in the pathogenesis of this phenomenon. However, these miRNAs have been tested only in explanted cirrhotic livers, when the liver damage has become chronic and irreversible. No data are available on the early phase of viral infection, such as early after liver transplantation (LT). In the present study, the expression of miR‐101, miR‐122, miR‐155, miR‐192, miR‐200c, miR‐338, and miR‐532 was determined by quantitative real‐time polymerase chain reaction in liver biopsies of HCV (n = 19) and HCV/HIV‐infected (n = 20) LT recipients, as well as in a control group (n = 18) of noninfected patients, transplanted for alcoholic cirrhosis. The timing of liver biopsy was 6 months post‐LT. None of the patients was treated with direct‐acting anti‐HCV drugs. All co‐infected recipients had suppressed HIV viral load. Grading and staging were assessed according to the Ishak Classification. HCV and HIV viral load were measured in the sera. miR‐101 (p = .03), miR‐122 (p = .012), and miR‐192 (p = .038) were significantly downregulated in HCV/HIV co‐infected and HCV mono‐infected recipients when compared with noninfected recipients, and such downregulation was more pronounced in co‐infected ones. Moreover, in co‐infected recipients but not in mono‐infected ones, miR‐101 inversely correlated with the peripheral HCV‐RNA levels (r = .41, p = .04) and miR‐122 inversely correlated with peripheral HCV‐RNA levels (r = .49, p = .03) and with the histological grading (r = .51, p = .02). In conclusion, as early as 6 months after LT, the presence of HIV‐HCV co‐infection enhanced a significant downregulation of certain miRNAs that showed a direct correlation with HCV viral load and liver inflammation. John Wiley and Sons Inc. 2021-05-04 2021-08 /pmc/articles/PMC8360178/ /pubmed/33818800 http://dx.doi.org/10.1002/jmv.26999 Text en © 2021 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Bulfoni, Michela Pravisani, Riccardo Dalla, Emiliano Cesselli, Daniela Hidaka, Masaaki Di Loreto, Carla Eguchi, Susumu Baccarani, Umberto miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation |
title | miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation |
title_full | miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation |
title_fullStr | miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation |
title_full_unstemmed | miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation |
title_short | miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation |
title_sort | mirna expression profiles in liver grafts of hcv and hiv/hcv‐infected recipients, 6 months after liver transplantation |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360178/ https://www.ncbi.nlm.nih.gov/pubmed/33818800 http://dx.doi.org/10.1002/jmv.26999 |
work_keys_str_mv | AT bulfonimichela mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation AT pravisaniriccardo mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation AT dallaemiliano mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation AT cessellidaniela mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation AT hidakamasaaki mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation AT diloretocarla mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation AT eguchisusumu mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation AT baccaraniumberto mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation |